Advertisement

Nephrolithiasis in the Elderly

  • Neera K. DahlEmail author
  • David S. Goldfarb
Chapter

Abstract

The geriatric population is both at higher risk of developing kidney stones and complications from medical or surgical treatment of stones. In this chapter, we review the risks for kidney stones and examine how these risk factors are affected by age. We also review current recommendations for treatment and suggest modifications to tailor therapy to the older age group.

Keywords

Aged Kidney stones Nephrolithiasis Urolithiasis 

References

  1. 1.
    Scales CD Jr, et al. Prevalence of kidney stones in the United States. Eur Urol. 2012;62(1):160–5.CrossRefGoogle Scholar
  2. 2.
    Soucie JM, et al. Demographic and geographic variability of kidney stones in the United States. Kidney Int. 1994;46(3):893–9.CrossRefGoogle Scholar
  3. 3.
    Otto BJ, et al. Age, body mass index, and gender predict 24-hour urine parameters in recurrent idiopathic calcium oxalate stone formers. J Endourol. 2017;31(12):1335–41.CrossRefGoogle Scholar
  4. 4.
    Taylor EN, Fung TT, Curhan GC. DASH-style diet associates with reduced risk for kidney stones. J Am Soc Nephrol. 2009;20(10):2253–9.CrossRefGoogle Scholar
  5. 5.
    Fakheri RJ, Goldfarb DS. Association of nephrolithiasis prevalence rates with ambient temperature in the United States: a re-analysis. Kidney Int. 2009;76(7):798.CrossRefGoogle Scholar
  6. 6.
    Mass AY, Goldfarb DS, Shah O. Taxi cab syndrome: a review of the extensive genitourinary pathology experienced by taxi cab drivers and what we can do to help. Rev Urol. 2014;16(3):99–104.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Worcester EM, Coe FL. Clinical practice. Calcium kidney stones. N Engl J Med. 2010;363(10):954–63.CrossRefGoogle Scholar
  8. 8.
    Lieske JC, et al. Stone composition as a function of age and sex. Clin J Am Soc Nephrol. 2014;9(12):2141–6.CrossRefGoogle Scholar
  9. 9.
    Ferraro PM, et al. Dietary and lifestyle risk factors associated with incident kidney stones in men and women. J Urol. 2017;198(4):858–63.CrossRefGoogle Scholar
  10. 10.
    Borghi L, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002;346(2):77–84.CrossRefGoogle Scholar
  11. 11.
    Pearle MS, et al. Medical management of kidney stones: AUA guideline. J Urol. 2014;192(2):316–24.CrossRefGoogle Scholar
  12. 12.
    Skolarikos A, et al. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines. Eur Urol. 2015;67(4):750–63.CrossRefGoogle Scholar
  13. 13.
    Escribano J, et al. Dietary interventions for preventing complications in idiopathic hypercalciuria. Cochrane Database Syst Rev. 2014;(2):Cd006022.Google Scholar
  14. 14.
    Qaseem A, et al. Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2014;161(9):659–67.CrossRefGoogle Scholar
  15. 15.
    Huen SC, Goldfarb DS. Adverse metabolic side effects of thiazides: implications for patients with calcium nephrolithiasis. J Urol. 2007;177(4):1238–43.CrossRefGoogle Scholar
  16. 16.
    Pannarale G. Optimal drug treatment of systolic hypertension in the elderly. Drugs Aging. 2008;25(1):1–8.CrossRefGoogle Scholar
  17. 17.
    Sakhaee K, et al. Nephrolithiasis-associated bone disease: pathogenesis and treatment options. Kidney Int. 2011;79(4):393–403.CrossRefGoogle Scholar
  18. 18.
    Usui Y, et al. Urolithiasis in geriatric patients. Tokai J Exp Clin Med. 2003;28(2):81–7.PubMedGoogle Scholar
  19. 19.
    Rule AD, et al. The ROKS nomogram for predicting a second symptomatic stone episode. J Am Soc Nephrol. 2014;25(12):2878–86.CrossRefGoogle Scholar
  20. 20.
    Goldfarb DS, Parks JH, Coe FL. Renal stone disease in older adults. Clin Geriatr Med. 1998;14(2):367–81.CrossRefGoogle Scholar
  21. 21.
    Walker V, Stansbridge EM, Griffin DG. Demography and biochemistry of 2800 patients from a renal stones clinic. Ann Clin Biochem. 2013;50(2):127–39.CrossRefGoogle Scholar
  22. 22.
    Perinpam M, et al. Effect of demographics on excretion of key urinary factors related to kidney stone risk. Urology. 2015;86(4):690–6.CrossRefGoogle Scholar
  23. 23.
    Friedlander JI, et al. Age-related changes in 24-hour urine composition must be considered in the medical management of nephrolithiasis. J Endourol. 2014;28(7):871–6.CrossRefGoogle Scholar
  24. 24.
    Scales CD, et al. Urinary stone disease: advancing knowledge, patient care, and population health. Clin J Am Soc Nephrol. 2016;11(7):1305–12.CrossRefGoogle Scholar
  25. 25.
    Taylor EN, et al. Nephrolithiasis and risk of incident bone fracture. J Urol. 2016;195(5):1482–6.CrossRefGoogle Scholar
  26. 26.
    Carbone LD, et al. Urinary tract stones and osteoporosis: findings from the Women’s Health Initiative. J Bone Miner Res. 2015;30(11):2096–102.CrossRefGoogle Scholar
  27. 27.
    Lucato P, et al. Nephrolithiasis, bone mineral density, osteoporosis, and fractures: a systematic review and comparative meta-analysis. Osteoporos Int. 2016;27(11):3155–64.CrossRefGoogle Scholar
  28. 28.
    Letavernier E, et al. Determinants of osteopenia in male renal-stone-disease patients with idiopathic hypercalciuria. Clin J Am Soc Nephrol. 2011;6(5):1149–54.CrossRefGoogle Scholar
  29. 29.
    Arrabal-Polo MA, et al. Effects of aminobisphosphonates and thiazides in patients with osteopenia/osteoporosis, hypercalciuria, and recurring renal calcium lithiasis. Urology. 2013;81(4):731–7.CrossRefGoogle Scholar
  30. 30.
    Pak CYC, et al. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions. J Urol. 2003;169(2):465–9.CrossRefGoogle Scholar
  31. 31.
    Pipili C, Oreopoulos DG. Vitamin D status in patients with recurrent kidney stones. Nephron Clin Pract. 2012;122(3–4):134–8.CrossRefGoogle Scholar
  32. 32.
    Nguyen S, et al. 25-hydroxyvitamin D in the range of 20 to 100 ng/mL and incidence of kidney stones. Am J Public Health. 2014;104(9):1783–7.CrossRefGoogle Scholar
  33. 33.
    Taylor EN, Hoofnagle AN, Curhan GC. Calcium and phosphorus regulatory hormones and risk of incident symptomatic kidney stones. Clin J Am Soc Nephrol. 2015;10(4):667–75.CrossRefGoogle Scholar
  34. 34.
    Tang J, Chonchol MB. Vitamin D and kidney stone disease. Curr Opin Nephrol Hypertens. 2013;22(4):383–9.CrossRefGoogle Scholar
  35. 35.
    Leaf DE, et al. Effect of vitamin D repletion on urinary calcium excretion among kidney stone formers. Clin J Am Soc Nephrol. 2012;7(5):829–34.CrossRefGoogle Scholar
  36. 36.
    Ferroni MC, et al. Vitamin D repletion in kidney stone formers: a randomized controlled trial. J Urol. 2017;197(4):1079–83.CrossRefGoogle Scholar
  37. 37.
    Jackson RD, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006;354(7):669–83.CrossRefGoogle Scholar
  38. 38.
    Bolland MJ, et al. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis. BMJ. 2011;342:d2040.CrossRefGoogle Scholar
  39. 39.
    Kopecky SL, et al. Lack of evidence linking calcium with or without vitamin D supplementation to cardiovascular disease in generally healthy adults: a clinical guideline from the National Osteoporosis Foundation and the American Society for Preventive Cardiology. Ann Intern Med. 2016;165(12):867–8.CrossRefGoogle Scholar
  40. 40.
    Kuehn BM. Uspstf: taking vitamin d and calcium doesn’t prevent fractures in older women. JAMA. 2012;308(3):225–6.CrossRefGoogle Scholar
  41. 41.
    Moyer VA, U.S.P.S.T. Force∗. Vitamin D and calcium supplementation to prevent fractures in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2013;158(9):691–6.PubMedGoogle Scholar
  42. 42.
    Harris SS, Dawson-Hughes B. Effects of hydration and calcium supplementation on urine calcium concentration in healthy postmenopausal women. J Am Coll Nutr. 2015;34(4):340–6.CrossRefGoogle Scholar
  43. 43.
    Levine BS, et al. Effect of calcium citrate supplementation on urinary calcium oxalate saturation in female stone formers: implications for prevention of osteoporosis. Am J Clin Nutr. 1994;60(4):592–6.CrossRefGoogle Scholar
  44. 44.
    Arrabal-Martin M, et al. Treatment with hydrochlorothiazide and alendronate in patients with stones and bone mineral density loss. Evolution of bone metabolism and calciuria with medical treatment. Arch Esp Urol. 2016;69(1):9–18.PubMedGoogle Scholar
  45. 45.
    Jehle S, Hulter HN, Krapf R. Effect of potassium citrate on bone density, microarchitecture, and fracture risk in healthy older adults without osteoporosis: a randomized controlled trial. J Clin Endocrinol Metab. 2013;98(1):207–17.CrossRefGoogle Scholar
  46. 46.
    Keddis MT, Rule AD. Nephrolithiasis and loss of kidney function. Curr Opin Nephrol Hypertens. 2013;22(4):390–6.CrossRefGoogle Scholar
  47. 47.
    Ferraro PM, et al. History of kidney stones and the risk of coronary heart disease. JAMA. 2013;310(4):408–15.CrossRefGoogle Scholar
  48. 48.
    Alexander RT, et al. Kidney stones and cardiovascular events: a cohort study. Clin J Am Soc Nephrol. 2014;9(3):506–12.CrossRefGoogle Scholar
  49. 49.
    Daels FPJ, et al. Age-related prevalence of diabetes mellitus, cardiovascular disease and anticoagulation therapy use in a urolithiasis population and their effect on outcomes: the Clinical Research Office of the Endourological Society Ureteroscopy Global Study. World J Urol. 2015;33(6):859–64.CrossRefGoogle Scholar
  50. 50.
    Trinchieri A, Esposito N, Castelnuovo C. Dissolution of radiolucent renal stones by oral alkalinization with potassium citrate/potassium bicarbonate. Arch Ital Urol Androl. 2009;81(3):188–91.PubMedGoogle Scholar
  51. 51.
    Drach GW, Griebling TL. Geriatric urology. J Am Geriatr Soc. 2003;51(7 Suppl):S355–8.CrossRefGoogle Scholar
  52. 52.
    Braude P, et al. Evaluation and establishment of a ward-based geriatric liaison service for older urological surgical patients: Proactive care of Older People undergoing Surgery (POPS)-Urology. BJU Int. 2017;120(1):123–9.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Section of NephrologyYale School of MedicineNew HavenUSA
  2. 2.Nephrology SectionNew York Harbor VA Healthcare System and NYU Langone HealthNew YorkUSA

Personalised recommendations